(Q36105649)
Statements
LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial (English)
B Zambrowicz
J Freiman
P M Brown
K S Frazier
A Turnage
J Bronner
D Ruff
M Shadoan
P Banks
F Mseeh
N C Goodwin
R Mabon
B A Harrison
A Wilson
A Sands
1 reference
1 reference